NO831170L - Salicylderivater, fremgangsmaate til deres fremstilling, farmasoeytiske preparater paa basis av disse forbindelsene og deres anvendelse - Google Patents

Salicylderivater, fremgangsmaate til deres fremstilling, farmasoeytiske preparater paa basis av disse forbindelsene og deres anvendelse

Info

Publication number
NO831170L
NO831170L NO831170A NO831170A NO831170L NO 831170 L NO831170 L NO 831170L NO 831170 A NO831170 A NO 831170A NO 831170 A NO831170 A NO 831170A NO 831170 L NO831170 L NO 831170L
Authority
NO
Norway
Prior art keywords
group
formula
atoms
acid
carboxyl
Prior art date
Application number
NO831170A
Other languages
English (en)
Norwegian (no)
Inventor
Volker Hitzel
Rudi Weyer
Karl Geisen
Harald Ritzel
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of NO831170L publication Critical patent/NO831170L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81Amides; Imides
    • C07D213/82Amides; Imides in position 3
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C65/00Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C65/21Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing ether groups, groups, groups, or groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pyridine Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Quinoline Compounds (AREA)
NO831170A 1982-03-31 1983-03-29 Salicylderivater, fremgangsmaate til deres fremstilling, farmasoeytiske preparater paa basis av disse forbindelsene og deres anvendelse NO831170L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19823211934 DE3211934A1 (de) 1982-03-31 1982-03-31 Salicylsaeurederivate, verfahren zu ihrer herstellung, pharmazeutische praeparate auf basis dieser verbindungen und ihre verwendung

Publications (1)

Publication Number Publication Date
NO831170L true NO831170L (no) 1983-10-03

Family

ID=6159858

Family Applications (1)

Application Number Title Priority Date Filing Date
NO831170A NO831170L (no) 1982-03-31 1983-03-29 Salicylderivater, fremgangsmaate til deres fremstilling, farmasoeytiske preparater paa basis av disse forbindelsene og deres anvendelse

Country Status (18)

Country Link
US (1) US4542127A (el)
EP (1) EP0090369B1 (el)
JP (1) JPS58177974A (el)
KR (1) KR840004080A (el)
AT (1) ATE17350T1 (el)
AU (1) AU1300383A (el)
CA (1) CA1197240A (el)
DE (2) DE3211934A1 (el)
DK (1) DK149383A (el)
ES (1) ES8401944A1 (el)
FI (1) FI831070L (el)
GR (1) GR79241B (el)
HU (1) HU190445B (el)
MA (1) MA19764A1 (el)
NO (1) NO831170L (el)
NZ (1) NZ203743A (el)
PT (1) PT76473B (el)
ZA (1) ZA832292B (el)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5216167A (en) * 1983-12-30 1993-06-01 Dr. Karl Thomae Gmbh Phenylacetic acid benzylamides
US5312924A (en) 1983-12-30 1994-05-17 Dr. Karl Thomae Gmbh Phenylacetic acid benzylamides
CN1597672A (zh) 1998-07-24 2005-03-23 拜尔公司 取代的苯甲酰基环己二酮类化合物
DE19920791A1 (de) * 1999-05-06 2000-11-09 Bayer Ag Substituierte Benzoylisoxazole
DE19921424A1 (de) 1999-05-08 2000-11-09 Bayer Ag Substituierte Benzoylketone
DE19946853A1 (de) 1999-09-30 2001-04-05 Bayer Ag Substituierte Arylketone
US7985743B1 (en) * 2005-07-22 2011-07-26 Gene A. Tabish Topical pain reliever and method of making the same
JP5887346B2 (ja) 2010-08-27 2016-03-16 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング Kcnq2/3調節因子としての置換キノリン−3−カルボキサミド
NZ604745A (en) 2010-08-27 2015-01-30 Gruenenthal Chemie Substituted 2-oxy-quinoline-3-carboxamides as kcnq2/3 modulators
EP2609086B1 (en) 2010-08-27 2015-02-25 Grünenthal GmbH Substituted 2-oxo- and 2-thioxo-dihydroquinoline-3-carboxamides as kcnq2/3 modulators
US8470852B2 (en) 2010-08-27 2013-06-25 Gruenenthal Gmbh Substituted 2-amino-quinoline-3-carboxamides as KCNQ2/3 modulators
MX2013002295A (es) 2010-09-01 2013-05-09 Gruenenthal Gmbh 1-oxo-dihidroisoquinolin-3-carboxamidas sustituidas como moduladores de kcnq2/3.
WO2023211990A1 (en) * 2022-04-25 2023-11-02 Siteone Therapeutics, Inc. Bicyclic heterocyclic amide inhibitors of na v1.8 for the treatment of pain

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1185180B (de) * 1963-10-19 1965-01-14 Hoechst Ag Verfahren zur Herstellung von Benzolsulfonylharnstoffen
DE2500157C2 (de) * 1975-01-03 1983-09-15 Hoechst Ag, 6230 Frankfurt N-Acyl-4-(2-aminoäthyl)-benzoesäuren, deren Salze und Ester, Verfahren zu deren Herstellung und deren Verwendung
DE2706977A1 (de) * 1977-02-18 1978-08-24 Hoechst Ag Benzoesaeuren und deren derivate sowie verfahren zu ihrer herstellung
DE3063878D1 (en) * 1979-07-13 1983-07-28 Thomae Gmbh Dr K Derivatives of carboxylic acids, their preparation and medicaments containing them
DE3100535A1 (de) * 1981-01-10 1982-08-12 Dr. Karl Thomae Gmbh, 7950 Biberach "neue carbonsaeure-derivate, ihre herstellung und ihre verwendung als arzneimittel"

Also Published As

Publication number Publication date
ATE17350T1 (de) 1986-01-15
HU190445B (en) 1986-09-29
ES521082A0 (es) 1984-01-01
DK149383A (da) 1983-10-01
FI831070L (fi) 1983-10-01
JPS58177974A (ja) 1983-10-18
DK149383D0 (da) 1983-03-30
MA19764A1 (fr) 1983-10-01
EP0090369B1 (de) 1986-01-08
KR840004080A (ko) 1984-10-06
GR79241B (el) 1984-10-22
NZ203743A (en) 1985-07-12
PT76473A (de) 1983-04-01
US4542127A (en) 1985-09-17
ZA832292B (en) 1983-12-28
PT76473B (de) 1986-01-24
DE3211934A1 (de) 1983-10-13
DE3361757D1 (en) 1986-02-20
EP0090369A1 (de) 1983-10-05
ES8401944A1 (es) 1984-01-01
AU1300383A (en) 1983-10-06
CA1197240A (en) 1985-11-26
FI831070A0 (fi) 1983-03-29

Similar Documents

Publication Publication Date Title
EP1960347B1 (en) 17-beta-hydroxysteroid dehydrogenase type 3 (17beta-hsd3) inhibitors
US4193926A (en) 4-(Polyalkoxy phenyl)-2-pyrrolidones
US4012495A (en) 4-(Polyalkoxyphenyl)-2-pyrrolidones
CA1113473A (en) 4-(nicotinamidoalkyl)-benzoic acids, the derivatives thereof and process for their manufacture
NO831170L (no) Salicylderivater, fremgangsmaate til deres fremstilling, farmasoeytiske preparater paa basis av disse forbindelsene og deres anvendelse
PT87783B (pt) Processo para a preparacao de compostos de amina ciclicos
NO153082B (no) Apparat for stapping av en rynket roerformet omhylling
DE2500157A1 (de) Benzoesaeuren und deren derivate sowie verfahren zu ihrer herstellung
NO764299L (el)
JPH0673038A (ja) ビフェニル誘導体、これらの化合物を含む医薬組成物及びそれらの調製法
NO884008L (no) Fremgangsmaate for fremstilling av 3,7-diazabicyclo(3,3,1)nonanforbindelser.
EP0085959B1 (en) Aromatic compounds
BG65889B1 (bg) Производно на пиридин-1-оксид и методи за неговото превръщане във фармацевтично полезни съединения
NO152005B (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive karboksylsyrederivater
NO820047L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive karboksylsyreamider
US3103516A (en) J-tertiaryaminq-lower alkyl-jb-meta-
EP0300725B1 (en) Tetrahydroisoquinolin-2-yl derivatives as thromboxane A2 antagonists
NO137965B (no) Analogifremgangsm}te for fremstilling av nye cykliske terapeutisk aktive urinstoffderivater og salter av disse med farmas¦ytisk akseptable syrer
US3845093A (en) Dibenzo(a,d)cycloheptene-10-carbonitriles
AU2005296674B2 (en) Ester derivative and pharmaceutical use thereof
US4442102A (en) 1,5-Diphenylpyrazolin-3-one compounds, process and intermediates for preparation thereof and pharmaceutical compositions containing same
NO145209B (no) Apparat for magnetisk paavirkning av en stroemmende vaeske
JPH062744B2 (ja) 3−アミノカルボニルメトキシ−5−フエニルピラゾ−ル化合物、その製法、およびこれを含有する抗不整脈作用を有する薬剤
EP0185079B1 (en) N-substituted butyramide derivatives
US5013734A (en) Novel esters of phenylalkanoic acid